Allurion Technologies, Inc. Net Income (Loss) Attributable to Parent, Diluted
Allurion Technologies, Inc. (ALUR) reported Net Income (Loss) Attributable to Parent, Diluted of $8.74 million for the 3-month period ending 2024-09-30, per its 10-Q/A filed 2025-08-28.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToParentDiluted · last filed 2025-08-28
- Allurion Technologies, Inc. net income (loss) attributable to parent, diluted for the quarter ending 2024-09-30 was $8.74M.
- Allurion Technologies, Inc. net income (loss) attributable to parent, diluted for the quarter ending 2024-06-30 was -$2.16M.
- Allurion Technologies, Inc. net income (loss) attributable to parent, diluted for the quarter ending 2024-03-31 was $1.89M.
- Allurion Technologies, Inc. net income (loss) attributable to parent, diluted for the quarter ending 2023-09-30 was -$21.89M.
| Period end | Net Income (Loss) Attributable to Parent, Diluted 3 month | Net Income (Loss) Attributable to Parent, Diluted 3 month as first filed | Net Income (Loss) Attributable to Parent, Diluted 6 month | Net Income (Loss) Attributable to Parent, Diluted 9 month |
|---|---|---|---|---|
| 2024-09-30 | $8.74M 10-Q/A · filed 2025-08-28 | $6.57M derived: sum of 2 quarters · filed 2025-08-28 | -$5.80M 10-Q/A · filed 2025-08-28 | |
| 2024-06-30 | -$2.16M 10-Q · filed 2024-08-14 | $3.28M 10-Q · filed 2024-08-14 | ||
| 2024-03-31 | $1.89M 10-Q/A · filed 2025-08-28 | $5.48M 10-Q · filed 2024-05-14 | ||
| 2023-09-30 | -$21.89M 10-Q/A · filed 2025-08-28 | -$44.61M derived: sum of 2 quarters · filed 2025-08-28 | -$63.12M 10-Q/A · filed 2025-08-28 | |
| 2023-06-30 | -$22.72M 10-Q · filed 2024-08-14 | -$41.24M 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | -$18.52M 10-Q/A · filed 2025-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |